Analyst Price Targets — SNPS
| Date | Analyst | Firm | Target | Price @ Post | Source | Headline |
|---|---|---|---|---|---|---|
| February 25, 2026 9:31 pm | James Schneider | Goldman Sachs | $600.00 | $449.17 | StreetInsider | Goldman Sachs on Synopsys (SNPS): 'We expect the stock to be range bound' |
| February 20, 2026 2:53 pm | — | HSBC | $455.00 | $444.62 | TheFly | Synopsys downgraded to Hold from Buy at HSBC |
| January 13, 2026 10:02 am | — | Piper Sandler | $520.00 | $533.42 | TheFly | Synopsys downgraded to Neutral from Overweight at Piper Sandler |
| December 12, 2025 1:46 pm | — | Morgan Stanley | $550.00 | $462.05 | TheFly | Synopsys price target raised to $550 from $510 at Morgan Stanley |
| December 11, 2025 2:15 pm | — | Needham | $580.00 | $470.90 | TheFly | Synopsys price target raised to $580 from $550 at Needham |
| December 11, 2025 11:35 am | — | Piper Sandler | $602.00 | $475.73 | TheFly | Synopsys price target lowered to $602 from $630 at Piper Sandler |
| December 11, 2025 11:25 am | Joe Quatrochi | Wells Fargo | $500.00 | $475.73 | TheFly | Synopsys price target raised to $500 from $445 at Wells Fargo |
| December 11, 2025 11:12 am | Jason Celino | KeyBanc | $600.00 | $475.73 | TheFly | Synopsys price target raised to $600 from $575 at KeyBanc |
| November 25, 2025 11:22 am | Joe Quatrochi | Wells Fargo | $445.00 | $404.63 | TheFly | Synopsys price target lowered to $445 from $550 at Wells Fargo |
| October 2, 2025 11:12 am | — | BNP Paribas | $425.00 | $488.78 | TheFly | Synopsys initiated with an Underperform at BNP Paribas Exane |
This site can’t be displayed in an embedded view
Some publishers block loading inside other sites for security reasons. You can open the article in a new tab instead.
Latest News for SNPS

Synopsys (SNPS) closed the most recent trading day at $449.58, moving +1.91% from the previous trading session.

In today's video, I discuss recent updates affecting Synopsys (SNPS +4.69%) and other AI stocks. To learn more, check out the short video, consider subscribing, and click the special offer link below.

Synopsys (SNPS) remains a Buy, with shares offering 12% upside to a $468 target as integration with Ansys progresses smoothly. Q1 results exceeded consensus, driven by Ansys synergy: revenue up 65.5% YoY, adjusted EPS up 24%, and strong demand in Design Automation. SNPS trades at a discount to its five-year historical multiples, with sector premium narrowing and valuation reset creating a compelling entry point.

Synopsys (SNPS) is rated a Buy with a $519.12 12-month price target, reflecting derisked China headwinds and Ansys-driven growth. China-related revenue disruptions are fully factored into guidance, offering pure upside if conditions improve, while downside is limited. The Ansys acquisition expands SNPS's TAM by 1.5x and accelerates integration of multiphysics simulation, enhancing cross-selling and competitive…

Synopsys is working with EMA and Cesium, part of Bentley Systems, to test equipment functionality by virtually replicating components, systems, and the lunar environment Key Highlights NASA's Johnson Space Center in Houston taps Synopsys and Electro Magnetic Applications, Inc. (EMA) to research Artemis spacesuit charging levels resulting from exposure to the lunar environment Cesium and Synopsys are collaborating…
🧮 Earnings Move Analyzer
Insider Trading
Insider Trading
| Name | Role | Date | Type | Shares | Price | Form | Link |
|---|
Senate Trading
Senate Trading Disclosures
| Name | Transaction Date | Type | Asset | Amount | Link |
|---|
U.S. House Trading
House Trades Disclosures
| Name | Transaction Date | Type | Asset | Amount | Link |
|---|
Options Chain Settings
Changes apply instantly as you toggle. Tap Done when finished.
Options Chain
Select an expiration to expand. Bid/Ask are shown first (before Mark) on both sides.
